Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion.
Degenring
Robert F
RF
Department of Ophthalmology, Faculty for Clinical Medicine Mannheim, Ruprecht-Karls-University, Heidelberg, Germany. robert.degenring@augen.ma.uni-heidelberg.de
Kamppeter
Bernd
B
Kreissig
Ingrid
I
Jonas
Jost B
JB
D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D007267:Injections; D007368:Interferometry; D008269:Macular Edema / Q000188:drug therapy / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D008297:Male; D012170:Retinal Vein Occlusion / Q000150:complications / Q000188:drug therapy / Q000473:pathology* / Q000503:physiopathology*; D014054:Tomography; D014222:Triamcinolone Acetonide / Q000627:therapeutic use*; D014792:Visual Acuity; D014822:Vitreous Body
D000893:Anti-Inflammatory Agents; D014222:Triamcinolone Acetonide